These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 24238156)

  • 1. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors.
    Miller IM; Ellervik C; Yazdanyar S; Jemec GB
    J Am Acad Dermatol; 2013 Dec; 69(6):1014-24. PubMed ID: 24238156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis.
    Miller IM; Skaaby T; Ellervik C; Jemec GB
    Br J Dermatol; 2013 Dec; 169(6):1180-7. PubMed ID: 23815240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.
    Shapiro J; Cohen AD; Weitzman D; Tal R; David M
    J Am Acad Dermatol; 2012 Feb; 66(2):252-8. PubMed ID: 21742411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
    Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
    Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cardiovascular risk factors in patients with psoriasis.
    Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
    J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of psoriasis as independent predictor of cardiovascular disease: a meta-regression analysis.
    Gaeta M; Castelvecchio S; Ricci C; Pigatto P; Pellissero G; Cappato R
    Int J Cardiol; 2013 Oct; 168(3):2282-8. PubMed ID: 23490084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
    Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: cardiovascular risk factors and other disease comorbidities.
    Wu Y; Mills D; Bala M
    J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and comorbidities of psoriasis.
    Ayala F; Ayala F
    J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
    Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
    Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities.
    Mahé E; Maccari F; Beauchet A; Lahfa M; Barthelemy H; Reguiaï Z; Beneton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Pauwels C; Avenel-Audran M; Goujon-Henry C; Descamps V; Begon E; Sigal ML;
    Br J Dermatol; 2013 Oct; 169(4):889-95. PubMed ID: 23937622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011.
    Armstrong AW; Schupp C; Bebo B
    Dermatology; 2012; 225(2):121-6. PubMed ID: 23108113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.